Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

  1. Froyman, W.
  2. Landolfo, C.
  3. De Cock, B.
  4. Wynants, L.
  5. Sladkevicius, P.
  6. Testa, A.C.
  7. Van Holsbeke, C.
  8. Domali, E.
  9. Fruscio, R.
  10. Epstein, E.
  11. dos Santos Bernardo, M.J.
  12. Franchi, D.
  13. Kudla, M.J.
  14. Chiappa, V.
  15. Alcazar, J.L.
  16. Leone, F.P.G.
  17. Buonomo, F.
  18. Hochberg, L.
  19. Coccia, M.E.
  20. Guerriero, S.
  21. Deo, N.
  22. Jokubkiene, L.
  23. Kaijser, J.
  24. Coosemans, A.
  25. Vergote, I.
  26. Verbakel, J.Y.
  27. Bourne, T.
  28. Van Calster, B.
  29. Valentin, L.
  30. Timmerman, D.
  31. Show all authors +
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2019

Volume: 20

Issue: 3

Pages: 448-458

Type: Article

DOI: 10.1016/S1470-2045(18)30837-4 GOOGLE SCHOLAR

Sustainable development goals